| Cell line name |
OVPA8 |
| Synonyms |
OVPA-8 |
| Accession |
CVCL_UC75 |
| Resource Identification Initiative |
To cite this cell line use: OVPA8 (RRID:CVCL_UC75) |
| Comments |
Population: Caucasian. Doubling time: ~44 hours (PubMed=30018258); 50-60 hours (DSMZ=ACC-871); 40-44 hours (ECACC=19062601). Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. |
| Sequence variations |
- Gene deletion; HGNC; HGNC:1101; BRCA2; Zygosity=Heterozygous (PubMed=30018258).
- Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Val1234Glnfs*8 (c.3695_3699GTAAA[1]) (c.3700_3704delGTAAA) (3819del5) (3819_3823delGTAAA); ClinVar=VCV000037542; Zygosity=Homozygous (PubMed=30018258).
- Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (PubMed=30018258).
|
| Disease |
High grade ovarian serous adenocarcinoma (NCIt: C105555) |
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
| Sex of cell |
Female |
| Age at sampling |
47Y |
| Category |
Cancer cell line |
| STR profile |
Source(s): DSMZ=ACC-871; ECACC=19062601; PubMed=30018258
Markers:| Amelogenin | X |
| CSF1PO | 10,11 |
| D1S1656 | 15 |
| D2S441 | 14 |
| D2S1338 | 21,25 |
| D3S1358 | 15 |
| D5S818 | 9,13 |
| D7S820 | 8,9 |
| D8S1179 | 11,14 (DSMZ=ACC-871; PubMed=30018258) 14 (ECACC=19062601) |
| D10S1248 | 14,15 |
| D12S391 | 21 |
| D13S317 | 11 |
| D16S539 | 12,14 |
| D18S51 | 12 |
| D19S433 | 13,15 |
| D21S11 | 29,30 |
| D22S1045 | 15 |
| FGA | 22,25 |
| Penta D | 13 |
| Penta E | 5 |
| TH01 | 8 |
| TPOX | 9,11 |
| vWA | 14 |
Run an STR similarity search on this cell line |
| Publications | PubMed=30018258; DOI=10.3390/ijms19072080; PMCID=PMC6073376 Patrycja Tudrej, Magdalena Olbryt, Ewa Zembala-Nozynska, Katarzyna A. Kujawa, Alexander J. Cortez, Anna Fiszer-Kierzkowska, Wojciech Piglowski, Barbara Nikiel, Magdalena Glowala-Kosinska, Aleksandra Bartkowska-Chrobok, Andrzej Smagur ...Show all 13 authors... , Wojciech Fidyk, Katarzyna Marta Lisowska; Show fewer authors Establishment and characterization of the novel high-grade serous ovarian cancer cell line OVPA8. Int. J. Mol. Sci. 19:2080.1-2080.26(2018) |
| Cross-references |
| Cell line collections (Providers) |
DSMZ; ACC-871
ECACC; 19062601
|
| Cell line databases/resources |
cancercelllines; CVCL_UC75
DSMZCellDive; ACC-871
|
| Encyclopedic resources |
Wikidata; Q98128408
|
| Entry history |
| Entry creation | 13-Nov-2018 |
| Last entry update | 19-Dec-2024 |
| Version number | 12 |
|---|